Balance Sheet of Pharmaceuticals Products of

India

------------------- in Rs. Cr. ------------------Dec

'04

Dec '03

Dec '02

Dec '01

12
mths

12 mths

12 mths

12 mths

12

12.03
9.53
0.00
2.50

12.03
9.53
0.00
2.50

12.03
9.53
0.00
2.50

-98.96

-91.93

-84.05

0.00
-86.93

0.00
-79.90

0.00
-72.02

62.64
21.84
84.48
-2.45

62.64
22.55
85.19
5.29

96.13
23.03
119.16
47.14

Dec '03

Dec '02

Dec '01

12
mths

12 mths

12 mths

12 mths

12

62.93
12.61
50.32

62.91
11.57
51.34

62.90
10.51
52.39

24.49
9.44
15.05

0.00
0.00

0.00
0.00

0.00
0.00

38.33
0.00

Inventories
Sundry Debtors
Cash and Bank Balance
Total Current Assets
Loans and Advances
Fixed Deposits
Total CA, Loans & Advances
Deffered Credit
Current Liabilities
Provisions
Total CL & Provisions
Net Current Assets

0.13
0.27
0.26
0.66
0.93
0.00
1.59
0.00
63.48
0.00
63.48
-61.89

0.08
0.11
0.24
0.43
0.56
0.00
0.99
0.00
55.79
0.00
55.79
-54.80

0.13
0.08
0.19
0.40
0.54
0.00
0.94
0.00
49.07
0.00
49.07
-48.13

0.46
0.06
0.03
0.55
0.52
0.00
1.07
0.00
8.36
0.00
8.36
-7.29

Miscellaneous Expenses
Total Assets

0.98
-10.59

1.01
-2.45

1.03
5.29

1.05
47.14

Contingent Liabilities

0.00
101.80

0.00

2.54

0.00

-93.84

-86.46

-78.16

Sources Of Funds
Total Share Capital
Equity Share Capital
Share Application Money
Preference Share Capital
Reserves
Revaluation Reserves
Networth
Secured Loans
Unsecured Loans
Total Debt
Total Liabilities

12.03
9.53
0.00
2.50
106.55
0.00
-94.52
62.64
21.29
83.93
-10.59
Dec
'04

Application Of Funds
Gross Block
Less: Accum. Depreciation
Net Block
Capital Work in Progress
Investments

Book Value (Rs)

Profit & Loss account of Pharmaceuticals

Products of India

------------------- in Rs. Cr. ------------------Dec

'04

Dec '03

Dec '02

Dec '01

12
mths

12 mths

12 mths

12 mths

12

Sales Turnover
Excise Duty
Net Sales
Other Income
Stock Adjustments
Total Income
Expenditure

0.06
0.00
0.06
2.59
0.00
2.65

0.02
0.00
0.02
2.79
-0.05
2.76

0.51
0.00
0.51
1.88
-0.23
2.16

2.54
0.00
2.54
3.16
-0.93
4.77

Raw Materials
Power & Fuel Cost
Employee Cost
Other Manufacturing Expenses
Selling and Admin Expenses
Miscellaneous Expenses
Preoperative Exp Capitalised
Total Expenses

0.00
0.15
0.54
0.36
0.00
1.54
0.00
2.59
Dec
'04

0.00
0.32
0.95
0.34
0.00
0.52
0.00
2.13

0.28
0.30
0.90
0.42
0.00
0.44
0.00
2.34

2.88
0.40
0.88
0.13
4.21
0.25
0.00
8.75

Dec '03

Dec '02

Dec '01

12
mths

12 mths

12 mths

12 mths

12

Operating Profit

-2.53

-2.16

-2.06

-7.14

PBDIT
Interest
PBDT
Depreciation
Other Written Off
Profit Before Tax
Extra-ordinary items
PBT (Post Extra-ord Items)
Tax
Reported Net Profit

0.06
6.60
-6.54
1.05
0.00
-7.59
0.00
-7.59
0.00
-7.59

0.63
6.61
-5.98
1.05
0.00
-7.03
0.00
-7.03
0.00
-7.03

-0.18
6.63
-6.81
1.07
0.00
-7.88
0.00
-7.88
0.00
-7.88

-3.98
6.72
-10.70
1.19
0.02
-11.91
0.00
-11.91
0.00
-11.92

2.59
0.00
0.00
0.00

2.13
0.00
0.00
0.00

2.06
0.00
0.00
0.00

5.87
0.00
0.00
0.00

95.30
-7.96

95.30
-7.38

95.30
-8.27

95.34
-12.50

0.00
101.80

0.00

0.00

0.00

-93.84

-86.46

-78.16

Income

Total Value Addition

Preference Dividend
Equity Dividend
Corporate Dividend Tax
Per share data (annualised)
Shares in issue (lakhs)
Earning Per Share (Rs)
Equity Dividend (%)
Book Value (Rs)

Cash Flow of Pharmaceuticals Products of

India

Net Profit Before Tax

Net Cash From Operating Activities
Net Cash (used in)/from
Investing Activities
Net Cash (used in)/from Financing Activities
Net (decrease)/increase In Cash and Cash
Equivalents
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalents

------------------- in Rs. Cr. ------------------Dec '01

De

12 mths

12

-11.92
-8.23
0.00
7.77
-0.46
0.49
0.03

-1

Key Financial Ratios of Pharmaceuticals

Products of India
Dec '04

Dec '03

Dec '02

Dec '01

10.00
--2.65
0.06
-1.03
--

10.00
--2.27
0.02
-1.06
--

10.00
--2.16
0.54
-1.08
--

10.00
--7.50
2.66
-89.27
--

-4,216.66
-135.09
-246.79
-246.79
-246.79
-286.41
-286.41
9.34
8.03
--14.35
-14.35
--

-10,800.00
-114.23
-212.81
-212.81
-212.81
-250.17
-250.17
17.14
8.09
--13.18
-13.18
--

-403.92
-130.96
-284.93
-284.93
-284.93
-329.70
-329.70
-23.62
9.86
--14.50
-14.50
-23.62

-281.97
-146.28
-185.66
-188.31
-187.90
-209.15
-209.15
-11.02
16.55
--21.48
-21.48
-40.59

0.03
0.02
---

0.02
0.02
---

0.02
0.02
---

0.01
0.07
---

Interest Cover
Total Debt to Owners Fund
Financial Charges Coverage Ratio
Financial Charges Coverage Ratio Post Tax
Management Efficiency Ratios

-0.15
-0.01
0.01

-0.06
-0.10
0.10

-0.19
--0.03
-0.03

-0.79
--0.59
-0.59

Inventory Turnover Ratio

Debtors Turnover Ratio
Investments Turnover Ratio
Fixed Assets Turnover Ratio
Total Assets Turnover Ratio
Asset Turnover Ratio

20.38
0.32
0.46
--0.01
0.00

35.13
0.21
0.25
--0.01
0.00

18.38
7.20
3.92
0.01
0.10
0.01

12.39
4.73
5.51
0.05
0.05
0.10

--371,340.00

---

---

-6.10

-986,400.00

-33,974.12

-1,035.66

--

--

54.90

113.72

--

--

--

--

--

--

--

154.75

Investment Valuation Ratios

Face Value
Dividend Per Share
Operating Profit Per Share (Rs)
Net Operating Profit Per Share (Rs)
Free Reserves Per Share (Rs)
Bonus in Equity Capital
Profitability Ratios
Operating Profit Margin(%)
Profit Before Interest And Tax Margin(%)
Gross Profit Margin(%)
Cash Profit Margin(%)
Adjusted Cash Margin(%)
Net Profit Margin(%)
Adjusted Net Profit Margin(%)
Return On Capital Employed(%)
Return On Net Worth(%)
Adjusted Return on Net Worth(%)
Return on Assets Excluding Revaluations
Return on Assets Including Revaluations
Return on Long Term Funds(%)
Liquidity And Solvency Ratios
Current Ratio
Quick Ratio
Debt Equity Ratio
Long Term Debt Equity Ratio
Debt Coverage Ratios

Average Raw Material Holding

Average Finished Goods Held
Number of Days In Working Capital
Profit & Loss Account Ratios
Material Cost Composition
Imported Composition of Raw Materials
Consumed
Selling Distribution Cost Composition

-1
-1
-1
-2
-2

-2

Expenses as Composition of Total Sales

Cash Flow Indicator Ratios

--

--

--

76.23

Dividend Payout Ratio Net Profit

Dividend Payout Ratio Cash Profit
Earning Retention Ratio
Cash Earning Retention Ratio
AdjustedCash Flow Times

------

------

------

------

Dec '04

Dec '03

Dec '02

Dec '01

-7.96
-101.80

-7.38
-93.84

-8.27
-86.46

-12.50
-78.16

Earnings Per Share

Book Value

BAFNA PHARMACEUTICALS LTD is EU - GMP, UK - MHRA, TGA Australia accredited facility in Non Betalactum solid oral Dosage forms providing

unmatched service by supplying hi-end pharmaceutical formulations to Regulated Market of United Kingdom, Europe and Australia apart from Emerg

Sri Lanka, Africa and CIS countries etc. Currently we manufacture and market over 336 licensed pharmaceutical products across various therapeut
have a global presence with 80 of our products being registered and marketed across Asia, Africa, UK, Europe and Australia. Looking ahead, we

poised to enter into the arena of Contract Research & Development on a large scale with our dedicated state - of - the - art the R&D facility in the regu